Further research work, including functional assays involving reporter systems in cell lines and studies investigating the mechanisms underlying the expression of Bcl-2 in cPNETs, will clarify the functional status of p53 in central primitive neuroectodermal tumours. The gene discussed is TP53; the disease is ependymoblastoma.